z-logo
open-access-imgOpen Access
Hemorrhage Risk Among Patients With Breast Cancer Receiving Concurrent Direct Oral Anticoagulants With Tamoxifen vs Aromatase Inhibitors
Author(s) -
TzuFei Wang,
Anna E. Clarke,
Arif Awan,
Peter Tanuseputro,
Marc Carrier,
Manish M. Sood
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.19128
Subject(s) - medicine , tamoxifen , breast cancer , apixaban , rivaroxaban , retrospective cohort study , population , cancer , aromatase inhibitor , oncology , warfarin , atrial fibrillation , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom